CClinicalTrials.gg
CompletedNCT02658110Updated Jan 18, 2016

Metabolic and Appetite Responses to Altered Timing of Whey Protein Ingestion

An interventional study of Whey Protein and Mixed Macronutrient Breakfast Meal in Obesity, Abdominal, sponsored by Northumbria University. Completed at 1 site in United Kingdom. Open to male participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2016-01-18.

Sponsored by Northumbria University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
Male
01

Study summary

The proposed study aims to determine the metabolic and appetite responses to standard breakfast and lunch meals whilst altering the timing of whey protein supplementation. Currently, the designs implemented in many studies mean that it is unclear whether an optimum time for whey protein consumption exists in order to promote the greatest acute health benefits. A number of studies have investigated the effects of whey protein when consumed as a preload to a subsequent meal, whilst benefits have also been shown when whey protein is ingested with a meal. The proposed study will therefore investigate strategies of whey protein supplementation that vary in their practical applicability, using meals that reflect regular eating behaviours throughout the population in a sample of overweight/obese individuals.

Findings from this study may provide important information regarding the efficacy of whey protein supplementation before, during and after a composite meal, and its effect on the handling of a subsequent mixed-macronutrient meal.

Read the detailed description

A randomised crossover design shall be implemented, whereby all participants complete 4 trials separated by a minimum of 3 days. On all visits participants shall consume a standardised mixed-macronutrient breakfast meal, followed 180 minutes later by consumption of a standard lunch meal. The timing of additional protein supplementation shall vary by trial, with participants consuming a shake containing 20g whey protein isolate either as a preload (15 minutes prior to breakfast), alongside the breakfast meal, or 15 minutes following breakfast consumption. A control trial shall also be completed without additional protein supplementation. At all supplementation time points participants shall consume either a flavoured whey protein shake or a flavoured water isovolumetric beverage ensuring that they remain blinded to the condition. Venous and capillary blood samples and visual analogue scales (for determination of subjective appetite sensations) shall be taken at regular intervals following both meals while the participant is rested.

02

Conditions studied

  • Obesity, Abdominal

Browse trials for

Keywords

  • Postprandial glycemia
  • Metabolic health measures
03

In context

Obesity, Abdominal

274 studies on the registry are indexed under Obesity, Abdominal; 44 are open to participants now.

This study's enrollment of 14 is below the median of 60 across 216 interventional studies indexed under Obesity, Abdominal.

Browse Obesity, Abdominal studies →

Lead sponsor

Northumbria University is the lead sponsor of 156 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Eligibility criteria

Criteria for inclusion are as follows:

  • Male
  • Aged 18-55 years
  • Abdominal obesity (Waist circumference > 102 cm)
  • Sedentary (not currently participating in structured physical activity)

Criteria for exclusion are as follows:

  • Metabolic disease or current illness
  • Regular breakfast skipper
  • Food allergies/intolerances
  • Eating disorders
  • Smoking
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
14 participants (actual)

Study arms

  • Sham comparator
    Non Protein Trial

    Mixed Macronutrient Breakfast Meal and Mixed Macronutrient Lunch Meal served without additional whey protein

    Other: Mixed Macronutrient Breakfast Meal · Other: Mixed Macronutrient Lunch Meal

  • Experimental
    Preload Trial

    Whey protein (20g) administered 15 minutes prior to Mixed Macronutrient Breakfast Meal

    Dietary Supplement: Whey Protein · Other: Mixed Macronutrient Breakfast Meal · Other: Mixed Macronutrient Lunch Meal

  • Experimental
    With Meal Trial

    Whey protein (20g) administered alongside Mixed Macronutrient Breakfast Meal

    Dietary Supplement: Whey Protein · Other: Mixed Macronutrient Breakfast Meal · Other: Mixed Macronutrient Lunch Meal

  • Experimental
    Post Meal Trial

    Whey protein (20g) administered 15 minutes after Mixed Macronutrient Breakfast Meal

    Dietary Supplement: Whey Protein · Other: Mixed Macronutrient Breakfast Meal · Other: Mixed Macronutrient Lunch Meal

Interventions

  • Dietary supplementWhey Protein

    20 g whey protein isolate (Arla Foods Ingredients Group) added to 200ml water and served as a beverage

  • OtherMixed Macronutrient Breakfast Meal

    A standardised mixed-macronutrient breakfast served to all participants. The macronutrient distribution of the breakfast is 13% protein, 70% carbohydrate, 17% fat (1958 kJ; 468 kcal total)

  • OtherMixed Macronutrient Lunch Meal

    A standardised mixed-macronutrient lunch served to all participants. The macronutrient distribution of the lunch is 14% protein, 51% carbohydrate, 35% fat (3506 kJ; 838 kcal total)

06

What researchers measure

Primary outcomes

  1. Postprandial blood glucose responses

    Blood glucose concentration determined in whole blood sampled at regular intervals post-breakfast and post-lunch

    Time frame: 0-360 minutes post breakfast

Secondary outcomes

  1. Acute subjective appetite responses

    Subjective appetite ratings determined from Visual Analogue Scales sampled at regular intervals

    Time frame: 0-360 minutes post breakfast

07

Study locations

1 site
  • Faculty of Health and Life Sciences, Northumbria University
    Newcastle upon Tyne, Tyne and Wear NE1 8ST, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02658110
Lead sponsor
Northumbria University
Responsible party
Sponsor
First posted
Jan 18, 2016
Start date
Jul 2015
Primary completion
Oct 2015
Completion
Oct 2015
Last update
Jan 18, 2016

Study contacts

Emma J Stevenson, PhD
study director · Northumbria University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion